The botulinum neurotoxin LD50 test - problems and solutions

Area of Science:

• Toxicology
• Pharmacology
• Animal Welfare

Background:

• The LD50 test, a standard for Botulinum Neurotoxin (BoNT) potency, is ethically problematic due to severe animal distress.
• EU regulations ban animal testing for cosmetics, yet BoNT testing persists.
• The European Pharmacopoeia permits validated alternative methods for BoNT testing.

Purpose of the Study:

• To highlight the ethical and regulatory conflicts surrounding the LD50 test for BoNT.
• To emphasize the non-implementation of validated alternative testing methods.
• To estimate the global number of animals used in BoNT LD50 tests.

Main Methods:

• Review of existing regulations and pharmacopoeia monographs.
• Analysis of ethical concerns regarding the LD50 test.
• Estimation of animal usage based on investigative data.

Main Results:

• The LD50 test causes significant animal suffering and contradicts EU cosmetic testing bans.
• Validated alternative assays for BoNT testing are not utilized by manufacturers.
• Regulatory authorities have not enforced the adoption of alternative methods or removal of the LD50 test.
• An estimated 600,000+ mice are used annually worldwide for BoNT LD50 tests.

Conclusions:

• The continued use of the LD50 test for BoNT is ethically unjustifiable and legally questionable.
• There is a critical need for the implementation and enforcement of validated alternative testing methods.
• Urgent action is required to reduce and ultimately replace animal testing in BoNT potency assays.